An official website of the United States government
NIH Guide: Weekly Index for October 4, 2024
Weekly NIH Guide Notices
October 4, 2024
Policy Notices
-
RESCINDED - Final Scientific Integrity Policy of the National Institutes of Health
(NOT-OD-24-178)Office of the Director, NIH
General Notices
-
Notice of Pre-Application Webinar for Notices of Funding Opportunity RFA-CA-25-009 and RFA-CA-25-010: Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT)
(NOT-CA-25-005)National Cancer Institute
-
Notice of Participation of NIDCR in RFA-AT-25-001, "HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)"
(NOT-DE-25-040)National Institute of Dental and Craniofacial Research
-
Notice of Information: Upcoming Prize Competition Announcement for the 2025 DEBUT Challenge
(NOT-EB-24-014)National Institute of Biomedical Imaging and Bioengineering
-
Notice of Informational Webinar for PAR-24-260 "Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) (R24 - Clinical Trial Not Allowed)"
(NOT-GM-25-001)National Institute of General Medical Sciences
-
Notice of NHLBI Participation in PA-25-080: NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
(NOT-HL-24-033)National Heart, Lung, and Blood Institute
-
Notice of Pre-Application Technical Assistance Webinar for RFA-HS-24-006 for National Coordinating Center (NCC) for AHRQ's Healthcare Extension Service - State-based Solutions to Healthcare Improvement (U54)
(NOT-HS-24-027)Agency for Healthcare Research and Quality
-
Notice of Pre-Application Technical Assistance Webinar for RFA-HS-24-005 for National Evaluation Center (NEC) for AHRQ's Healthcare Extension Service - State-based Solutions to Healthcare Improvement (U19)
(NOT-HS-25-001)Agency for Healthcare Research and Quality
-
Pre-Application Webinar for RFA-NR-25-001: Advancing Health Equity through Interventions to Prevent and Address Housing Instability (R01 Clinical Trial Optional)
(NOT-NR-25-001)National Institute of Nursing Research
-
NIH Entrepreneurship Boot Camp for pre-SBIR/STTR Innovators
(NOT-OD-25-004)Office of the Director, NIH
-
Retirement of NIHs eRA Commons Demo
(NOT-OD-25-005)National Institutes of Health
-
Request for Information (RFI): Harmonization of research metrics on alcohol use, misuse, pathology, and mortality internationally.
(NOT-AA-24-012)National Institute on Alcohol Abuse and Alcoholism
-
Request for Information (RFI): Soliciting Input on Priorities and Progress in Alzheimers Disease-Related Dementias Research
(NOT-NS-24-132)National Institute of Neurological Disorders and Stroke
Notice of Changes to Funding Opportunities
-
Notice of Participation of National Cancer Institute (NCI) in RFA-AT-24-010 "Whole Person Research and Coordination Center (Whole Person RCC) U24 (Clinical Trial Not Allowed)"
(NOT-CA-24-109)National Cancer Institute
-
Updates to NIGMS IMSD, G-RISE and Bridges to the Doctorate T32 Training Grant Applications for Due Dates on and after January 25, 2025
(NOT-GM-24-051)National Institute of General Medical Sciences
-
Updates to NIGMS Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP) (T32)
Training Grant Applications for Due Dates on and after January 25, 2025
(NOT-GM-24-052)National Institute of General Medical Sciences
-
Updates to NIGMS Predoctoral Basic Biomedical Sciences Research Training Program and Medical Scientist Training Program (MSTP) T32 Training Grant Applications for Due Dates on and after January 25, 2025
(NOT-GM-24-053)National Institute of General Medical Sciences
-
Notice of Change to Application Due Date for PAR-23-138 "Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)"
(NOT-GM-24-055)National Institute of General Medical Sciences
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
(NOT-DA-24-046)National Institute on Drug Abuse
-
Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
(NOT-DA-24-047)National Institute on Drug Abuse
-
Notice of Intent to Publish a Funding Opportunity Announcement for NINR Resources and Related Research Projects in Firearm Injury Prevention (R24 Clinical Trial Not Allowed)
(NOT-NR-24-012)National Institute of Nursing Research
Notices of Special Interest
-
Notice of Special Interest (NOSI): The Role of the Immune System in Aging Brain and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)
(NOT-AG-24-010)National Institute on Aging
Funding Opportunities
-
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
(PA-25-080)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Eye InstituteNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Library of MedicineNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeNational Center for Advancing Translational SciencesNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Research on Women's HealthNational Institute on Minority Health and Health DisparitiesNational Center for Advancing Translational SciencesDivision of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): Multiple dates, see announcement.
-
Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)
(PA-25-093)National Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
(PAR-24-293)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Eye InstituteNational Institute of Mental HealthNational Center for Complementary and Integrative HealthOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): Multiple dates, see announcement.
-
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
(PAR-24-294)National Institute of Neurological Disorders and StrokeNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Drug AbuseNational Institute of Dental and Craniofacial ResearchNational Institute of Environmental Health SciencesNational Eye InstituteNational Institute of Mental HealthNational Center for Complementary and Integrative HealthOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): Multiple dates, see announcement.
-
Centers for Precision Disease Modeling (U54) (Clinical Trials Not Allowed)
(PAR-24-305)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): December 15, 2024
-
Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)
(PAR-25-020)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): Multiple dates, see announcement.
-
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)
(PAR-25-050)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
(PAR-25-055)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
(PAR-25-061)Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): January 27, 2025
-
Centers on the Demography and Economics of Aging, Including Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (D&E Centers) (P30 Clinical Trial Optional)
(RFA-AG-25-007)National Institute on AgingApplication Receipt Date(s): December 10, 2024
-
Centers on the Demography and Economics of Aging and Alzheimers Disease and Alzheimers Disease-Related Dementias Coordinating Center (U24 Clinical Trial Optional)
(RFA-AG-25-008)National Institute on AgingApplication Receipt Date(s): January 10, 2025
-
Development of Alternative Human Models of Radiation-Induced Injuries (Extracorporeal Systems) (U01 Clinical Trial Not Allowed)
(RFA-AI-24-067)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): February 06, 2025
-
Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT)- Lung Cancer Screening (UG3/UH3 Clinical Trial Required)
(RFA-CA-25-009)National Cancer InstituteApplication Receipt Date(s): December 06, 2024
-
Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required)
(RFA-CA-25-010)National Cancer InstituteApplication Receipt Date(s): December 06, 2024
-
Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
(RFA-CA-25-013)National Cancer InstituteApplication Receipt Date(s): June 13, 2025
-
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed)
(RFA-DA-26-009)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed)
(RFA-DA-26-010)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster